NCT00985114View on ClinicalTrials.gov

Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Type II Diabetes
Interventions
DEVICE

EndoBarrier

EndoBarrier implant

BEHAVIORAL

Diet + Lifestyle Counseling

Multidisciplinary lifestyle and nutritional counseling

Trial Locations (3)

Unknown

Ziekenhuis Rijnstate Arnhem, Arnhem

Medisch Centrum Parkstad, Heerlen

University Hospital Maastricht, Maastricht

Sponsors
All Listed Sponsors
lead

Morphic Medical Inc.

INDUSTRY

NCT00985114 - Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity | Biotech Hunter | Biotech Hunter